298: Subcutaneous dexmedetomidine, why IV dextrose is given to patients with DKA, and a tip for responding to inpatient medical emergencies

Published: May 28, 2018, 7 a.m.

Show notes at pharmacyjoe.com/episode298. In this episode I ll: 1. Discuss an article about subcutaneously administered dexmedetomidine. 2. Answer the drug information question “Why is IV dextrose given to patients with DKA?” 3. Share a tip for responding to inpatient medical emergencies. The post 298: Subcutaneous dexmedetomidine, why IV dextrose is given to patients with DKA, and a tip for responding to inpatient medical emergencies appeared first on Pharmacy Joe.